---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-22-000076"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2022-05-06T23:59:59+00:00"
generated_at: "2026-06-25T22:50:46.044897+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics Pharma Services President Dr. Gina Wallar resigns; Jennifer Rose named interim lead

## Summary
- Dr. Gina M. Wallar resigns as President of Pharma Services Division effective May 27, 2022.
- Jennifer Rose, current VP of Pharma Sales and Project Management, will assume interim responsibility starting May 27, 2022.
- Ms. Rose joined NeoGenomics in December 2015.

## SEC filing metadata
- accession: 0001077183-22-000076
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2022-05-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000076/0001077183-22-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000076/neo-20220502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-22-000076
- JSON: https://secwatch.observer/filing/0001077183-22-000076.json
- Plain text: https://secwatch.observer/filing/0001077183-22-000076.txt

## Key facts
- Executive change
  Gina M. Wallar resigned as President, Pharma Services Division at NEOGENOMICS INC.
  - Action: resigned
  - Role: President, Pharma Services Division
  source text: On May 2, 2022, Dr. Gina M. Wallar, NeoGenomics, Inc.’s (the “Company”) current President, Pharma Services Division, informed the Company of her intention to resign from her role effective May 27, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000076/0001077183-22-000076-index.htm
- Executive change
  Jennifer Rose was appointed as Interim President, Pharma Services Division at NEOGENOMICS INC.
  - Action: assume interim responsibility
  - Role: Interim President, Pharma Services Division
  source text: In connection with Dr. Wallar’s departure, Ms. Jennifer Rose will assume interim responsibility for the Pharma Services Division beginning on May 27, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000076/0001077183-22-000076-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.